Bicycle Therapeutics
BCYC
10 hedge funds and large institutions have $55.7M invested in Bicycle Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
3.04% less ownership
Funds ownership: 36.01% → 32.97% (-3%)
9% less funds holding
Funds holding: 11 → 10 (-1)
24% less capital invested
Capital invested by funds: $73.4M → $55.7M (-$17.8M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.47M |
| 2 |
Morgan Stanley
New York
|
+$91 |
| 3 |
PHK
Point72 Hong Kong
Hong Kong
|
+$72 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$8.74M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$1.04M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$336K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$148K |
| 5 |
Millennium Management
New York
|
-$123K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Tybourne Capital Management
Hong Kong
| $18.5M | – | – | – |
|
|
SHI
2
SV Health Investors
Boston,
Massachusetts
| $18.1M | – | – | – |
|
|
AVA
3
Atlas Venture Advisors
Boston,
Massachusetts
| $12.8M | – | – | – |
|
|
4
Point72 Asset Management
Stamford,
Connecticut
| $3.61M | +$3.47M | +382,499 | New |
|
5
Victory Capital Management
San Antonio,
Texas
| $1.28M | -$36.2K | -4,000 | -3% |
|
|
LCM
6
Laurion Capital Management
New York
| $701K | -$148K | -16,344 | -18% |
|
|
PCM
7
Pentwater Capital Management
Naples,
Florida
| $496K | -$46.2K | -5,100 | -9% |
|
|
8
Millennium Management
New York
| $200K | -$123K | -13,579 | -39% |
|
|
ACM
9
Aquilo Capital Management
San Francisco,
California
| – | -$8.74M | -767,026 | Closed |
|
|
BCM
10
BlueCrest Capital Management
St Helier,
Jersey
| – | -$1.04M | -90,986 | Closed |
|
|
11
Norges Bank
Oslo,
Norway
| – | -$336K | -29,528 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$1K | -92 | Closed |
|
|
PHK
13
Point72 Hong Kong
Hong Kong
| – | +$72 | +8 | New |
|
|
14
Morgan Stanley
New York
| – | +$91 | +10 | New |
|
BCYC Hedge Fund Activity: Q4 2019 in Review
10 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q4 2019, worth a combined $55.7M — down 24% from $73.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BCYC and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.47M. The largest seller was Aquilo Capital Management, exiting entirely with an estimated $8.74M sold.
- 10 institutional investors held Bicycle Therapeutics (BCYC) as of Q4 2019, down from 11 in Q3 2019.
- Funds reported $55.7M of Bicycle Therapeutics stock for Q4 2019, down 24% quarter-over-quarter.
- 3 funds opened new Bicycle Therapeutics positions in Q4 2019 and 4 closed out, a net change of -1 holder.
- The largest Bicycle Therapeutics buyer in Q4 2019 was Point72 Asset Management, an estimated $3.47M added.
- The largest Bicycle Therapeutics seller in Q4 2019 was Aquilo Capital Management, an estimated $8.74M sold.
Based on aggregated 13F filings for Q4 2019.